A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancer-Reference-Cited by-同舟云学术

A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancer

Published:2013-01-13 Issue:4 Volume:71 Page:883-892
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Antonarakis Emmanuel S.,Heath Elisabeth I.,Posadas Edwin M.,Yu Evan Y.,Harrison Michael R.,Bruce Justine Y.,Cho Steve Y.,Wilding Gregory E.,Fetterly Gerald J.,Hangauer David G.,Kwan Min-Fun R.,Dyster Lyn M.,Carducci Michael A.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-013-2079-z.pdf

Reference25 articles.

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10–29

2. Antonarakis ES, Eisenberger MA (2011) Expanding treatment options for metastatic prostate cancer. N Engl J Med 364:2055–2058

3. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674

4. Chang YM, Kung HJ, Evans CP (2007) Non-receptor tyrosine kinases in prostate cancer. Neoplasia 9:90–100

5. Posadas EM, Al-Ahmadie H, Robinson VL et al (2009) FYN is overexpressed in human prostate cancer. BJU Int 103:171–177

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tirbanibulin (KX2‐391) analog KX2‐361 inhibits botulinum neurotoxin serotype A mediated SNAP‐25 cleavage in pre‐ and post‐intoxication models in cells;Drug Development Research;2024-08-21

2. The emerging role of osteoclasts in the treatment of bone metastases: rationale and recent clinical evidence;Frontiers in Oncology;2024-08-01

3. PM534, an Optimized Target-Protein Interaction Strategy through the Colchicine Site of Tubulin;Journal of Medicinal Chemistry;2024-01-31

4. Role of sodium taurocholate cotransporting polypeptide (NTCP) in HBV-induced hepatitis: Opportunities for developing novel therapeutics;Biochemical Pharmacology;2024-01

5. Recent advances of small-molecule c-Src inhibitors for potential therapeutic utilities;Bioorganic Chemistry;2024-01